newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Participate in Two Upcoming Investor Conferences

  • Minerva Neurosciences, Inc. announced management will participate in two investor conferences in New York, NY.
  • The Wells Fargo Healthcare Conference is scheduled for Tuesday, September 8, featuring 1x1 meetings.
  • The 2026 Cantor Global Healthcare Conference is scheduled for Wednesday, September 9, with a fireside chat & 1x1 meetings from 2:45 to 3:15 PM EDT.
  • A live webcast of the events will be available on the company website, with a replay accessible approximately two hours after the events conclude.
  • Minerva Neurosciences is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders.
  • The company is currently conducting a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia.